ROMEO (Rosuvastatin in Metabolic syndrOme)

Status Completed

Clinical Trial Summary

The primary objective of this study is to compare the effect of rosuvastatin 10mg with atorvastatin 10mg after 6 weeks of treatment in the ratio of ApoB/ApoA1 in subjects with metabolic syndrome.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00395486
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 4
Start date	September 2006
Completion date	June 2008

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02702375` - Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases	N/A
Completed	`NCT02649348` - Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome	N/A
Completed	`NCT02918422` - Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption	N/A
Completed	`NCT02356952` - Effect of a Low Glycemic Index on Metabolic Syndrome	N/A
Completed	`NCT02337933` - Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome	Phase 2
Completed	`NCT02459691` - Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)	N/A
Completed	`NCT02402985` - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics	N/A
Completed	`NCT01694056` - Soy Protein Intake and the Metabolic Syndrome	N/A
Completed	`NCT00344903` - Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort	N/A
Recruiting	`NCT00408824` - Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)	N/A
Completed	`NCT00362908` - Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome	N/A
Completed	`NCT00140816` - Dairy Products and Metabolic Effects (Norwegian Part)	N/A
Completed	`NCT00101517` - Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease	N/A
Completed	`NCT00166036` - Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells	Phase 2
Completed	`NCT00455325` - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)	Phase 2
Recruiting	`NCT00177892` - Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress	N/A
Completed	`NCT00074451` - Genomewide Search for Loci Underlying Metabolic Syndrome
Completed	`NCT00073775` - Epidemiology of Stress and the Metabolic Syndrome	N/A
Completed	`NCT00200993` - Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)	Phase 2
Completed	`NCT00864461` - Frequency of Metabolic Syndrome in Down Syndrome Patients	N/A